General Motors has officially confirmed plans to reveal the next-generation Chevy Silverado and GMC Sierra later this year. Confirmation was provided via the automaker’s Q4 2025 earnings report, where ...

Global pharmaceutical company Eli Lilly (NYSE:LLY) will be reporting earnings this Wednesday before market hours. Here’s what to expect. Eli Lilly beat analysts’ revenue expectations by 9.7% last ...

It’s official: the next-generation Chevrolet Silverado and GMC Sierra pickup trucks will come out of hiding later this year. The reveal is part of the automaker’s expansion of U.S. production capacity ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report? It is worth considering Eli Lilly (LLY), which belongs to the Zacks Large ...

It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ...

Eli Lilly (LLY) has agreed to acquire biotechnology company Orna Therapeutics for up to $2.4B in cash, inclusive of an upfront payment and subsequent payments upon achievement of certain clinical ...

Eli Lilly is rated SELL due to lofty valuation, despite extraordinary execution and recent market leadership in GLP-1 and obesity drugs. LLY's current $950B market cap implies sustained 25% annual ...

Eli Lilly posted fourth-quarter earnings and revenue and 2026 guidance that blew past estimates, as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro soars. The ...

Eli Lilly beat earnings soundly yesterday. Today, the stock is selling off on new competition from Hims & Hers Health. Earnings weren't the problem. Lilly beat analyst forecasts for $6.93 per share in ...

Eli Lilly and Company (NYSE:LLY) is among the most profitable healthcare stocks to buy. On January 26, Srikripa Devarakonda, an analyst at Truist Financial, maintained a Buy rating on Eli Lilly and ...